Distributing since 1889 • Employee Owned for Better Service
Your 1st Choice!
Sign In
Quick Search:

Shopping Cart Cart |  My Account |  View Printable Page Print
Product Detail

Pharmacokinetics in Drug Development: Problems and Challenges in Oncology

Bonate, Peter L.
Pharmacokinetics in Drug Development: Problems and Challenges in Oncology Cover Image
Pricing & Availability
Available: 0
List Price:$219.99

Email this title to a friend Email this title to a friend
Printer friendly version Printer friendly version

Other formats:
Book Information
Edition: 1st
Publisher: Springer Nature
ISBN: 3-319-39051-1 (3319390511)
ISBN-13: 978-3-319-39051-2 (9783319390512)
Old Edition: 1-4419-7936-0
Binding: Hardcover
Copyright: 2016
Publish Date: 10/16
Volume: 4
Weight: 1.42 Lbs.
Pages: 330
Subject Class: PRM (Pharmacology)
Doody Star Rating: 3
Return Policy: Returns accepted up to 12 months provided no other recalls or return restrictions apply.
Contributing Authors: View
 
Class Specifications
Discipline: Pharmacology
Subject Definition: Pharmacokinetics; Drug Design
NLM Class: QV 38
LC Class: RM301.5
Abstract: In this volume, the specific challenges and problems facing the evaluation of new oncology agents are explored with regards to pharmacokinetic, pharmacodynamic modeling and clinical pharmacology development strategies. This book delivers, with an emphasis on the oncology therapeutic area, the goals set in the first three volumes: namely--to provide clinical pharmacologists practical insights for the application of pharmacology, pharmacokinetics and pharmacodynamics for new drug development strategies. Pharmacokinetic-pharmacodynamic concepts for tyrosine kinases, the evaluation of cardiac repolarization prolongation through QTc interval effects, efficacy-and safety-response analyses to support new drug approvals, clinical and preclinical tumor growth modeling, and flat- vs weight-based dose selection are showcased from an oncology clinical pharmacologist's point-of-view. Oncology development strategies are surveyed for new FDA-approvals to identify patterns in expectations at time of first approval. The special considerations necessary to address combination drug development, metronomics, biosimilars and breakthrough therapies are also presented.

Follow Matthews Book Co. on:
Follow Matthews Book Co. on Twitter

Copyright © 2001-2026 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews Privacy Statement